VahatiCor Enrolls First U.S. Patient in A-FLUX SERRA-I Trial
SANTA CLARA, Calif., June 17, 2026 VahatiCor, Inc., a medical device company focused on developing innovative therapies for coronary...
AI drug discovery Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
Medical Devices, Diagnostics, Radiation-Emitting Products
SANTA CLARA, Calif., June 17, 2026 VahatiCor, Inc., a medical device company focused on developing innovative therapies for coronary...
BASEL, Switzerland, June 17, 2026 FiberSense AG has announced that its innovative FiberSense Continuous Glucose Monitoring (CGM) System has...
NEW YORK, June 16, 2026 AccurKardia announced that its AK-AVSâ„¢ aortic valve stenosis screening software has been accepted into...
NEW YORK, June 16, 2026 Intelligent Bio Solutions (INBS) announced the initiation of a critical clinical Interference Study designed...
HOUSTON, Texas, June 16, 2026 Nexalin Technology announced that two clinical abstracts evaluating its proprietary Deep Intracranial Frequency Stimulation...
OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...
LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...
PEACHTREE CORNERS, Ga., June 2026 Guided Therapeutics, Inc. announced the submission of its Premarket Approval (PMA) clinical report to...
FRIENDSWOOD, Texas, June 16, 2026 Castle Biosciences has announced that its TissueCypher® Barrett’s Esophagus Test has surpassed 100,000 clinical...
BOCA RATON, Fla., June 2026 SurGenTec® has announced U.S. FDA clearance for its ION-L™ Lumbar Facet Fixation System, a...
